(Q41124612)

27 September 2017

Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis (English)

1 reference

27 September 2017

Liu X

1

1 reference

27 September 2017

Linnington C

2

1 reference

27 September 2017

Webster HD

3

1 reference

27 September 2017

Lassmann S

4

1 reference

27 September 2017

Yao DL

5

1 reference

27 September 2017

Hudson LD

6

1 reference

27 September 2017

Wekerle H

7

1 reference

27 September 2017

Kreutzberg GW

8

1 reference

27 September 2017

1 March 1997

1 reference

Journal of Neuroscience Research

27 September 2017

1 reference

27 September 2017

47

1 reference

27 September 2017

5

1 reference

27 September 2017

531-538

1 reference

Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons

27 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Insulin-like growth factor-1 stimulation of lymphopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Protein growth factors as potential therapies for central nervous system demyelinative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rat: distinct nature of parenchymal and perivascular infiltrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

TCR peptide therapy in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2819970301%2947%3A5%3C531%3A%3AAID-JNR8%3E3.0.CO%3B2-I

10.1002/(SICI)1097-4547(19970301)47:5<531::AID-JNR8>3.0.CO;2-I

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference